TRLS vs. IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHC
Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry.
Trellus Health vs. Its Competitors
Trellus Health (LON:TRLS) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.
6.2% of Trellus Health shares are owned by institutional investors. 21.5% of Trellus Health shares are owned by insiders. Comparatively, 66.0% of IQ-AI shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Trellus Health's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.
Trellus Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500.
IQ-AI has higher revenue and earnings than Trellus Health.
IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.
Summary
IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.
Get Trellus Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.
Trellus Health Competitors List
Related Companies and Tools
This page (LON:TRLS) was last updated on 9/13/2025 by MarketBeat.com Staff